发明名称 |
USE OF LAQUINIMOD TO DELAY HUNTINGTON'S DISEASE PROGRESSION. |
摘要 |
The subject invention provides methods of treating or delaying disease progression in a subject afflicted with Huntington's disease (HD) comprising administering to the subject 0.5-1.5 mg/day laquinimod. The subject invention also provides packages, therapeutic packages and pharmaceutical compositions, comprising one or more unit doses of 0.5-1.5 mg laquinimod for treating or delaying disease progression in a subject afflicted with HD. Also disclosed is use of laquinimod in the manufacture of a medicament comprising one or more unit doses of 0.5-1.5 mg laquinimod for use in treating or delaying disease progression in a subject afflicted HD. |
申请公布号 |
MX2016008027(A) |
申请公布日期 |
2016.10.12 |
申请号 |
MX20160008027 |
申请日期 |
2014.12.18 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
Esther Lukasiewicz HAGAI;Sigal MELAMED-GAL;Eli AYAL;Anna WICKENBERG |
分类号 |
A61K31/4704;A61P25/00 |
主分类号 |
A61K31/4704 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|